Comparing two assays for clinical genomic profiling: the devil is in the data.
about
Comparing two assays for clinical genomic profiling: the devil is in the data [Letter of clarification].Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
P2860
Comparing two assays for clinical genomic profiling: the devil is in the data.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Comparing two assays for clinical genomic profiling: the devil is in the data.
@ast
Comparing two assays for clinical genomic profiling: the devil is in the data.
@en
type
label
Comparing two assays for clinical genomic profiling: the devil is in the data.
@ast
Comparing two assays for clinical genomic profiling: the devil is in the data.
@en
prefLabel
Comparing two assays for clinical genomic profiling: the devil is in the data.
@ast
Comparing two assays for clinical genomic profiling: the devil is in the data.
@en
P2093
P2860
P356
P1476
Comparing two assays for clinical genomic profiling: the devil is in the data.
@en
P2093
Garrett M Frampton
Jeffrey S Ross
Phil J Stephens
Rachel M Squillace
Vincent A Miller
P2860
P304
P356
10.2147/OTT.S88908
P407
P577
2015-08-24T00:00:00Z